This gene is a member of the frizzled gene family. Members of this family encode seven-transmembrane domain proteins that are receptors for the Wingless type MMTV integration site family of signaling proteins. Frizzled-4 is the only representative of frizzled family members that binds strongly an additional ligand Norrin that is functionally similar but structurally different from Wingless type proteins. FZD4 signaling induced by Norrin regulates vascular development of vertebrate retina and controls important blood vessels in the ear. Most frizzled receptors are coupled to the beta-catenin canonical signaling pathway. This protein may play a role as a positive regulator of the Wingless type MMTV integration site signaling pathway. A transcript variant retaining intronic sequence and encoding a shorter isoform has been described, however, its expression is not supported by other experimental evidence.
^Kirikoshi H, Sagara N, Koike J, Tanaka K, Sekihara H, Hirai M, Katoh M (Dec 1999). "Molecular cloning and characterization of human Frizzled-4 on chromosome 11q14-q21". Biochem Biophys Res Commun264 (3): 955–61. doi:10.1006/bbrc.1999.1612. PMID10544037.
Li Y, Fuhrmann C, Schwinger E et al. (1992). "The gene for autosomal dominant familial exudative vitreoretinopathy (Criswick-Schepens) on the long arm of chromosome 11". Am. J. Ophthalmol.113 (6): 712–3. PMID1598965.
Sagara N, Kirikoshi H, Terasaki H et al. (2001). "FZD4S, a splicing variant of frizzled-4, encodes a soluble-type positive regulator of the WNT signaling pathway". Biochem. Biophys. Res. Commun.282 (3): 750–6. doi:10.1006/bbrc.2001.4634. PMID11401527.
Chen W, ten Berge D, Brown J et al. (2003). "Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4". Science301 (5638): 1391–4. doi:10.1126/science.1082808. PMID12958364.
Toomes C, Downey LM, Bottomley HM et al. (2004). "Identification of a fourth locus (EVR4) for familial exudative vitreoretinopathy (FEVR)". Mol. Vis.10: 37–42. PMID14737064.
Yao R, Natsume Y, Noda T (2005). "MAGI-3 is involved in the regulation of the JNK signaling pathway as a scaffold protein for frizzled and Ltap". Oncogene23 (36): 6023–30. doi:10.1038/sj.onc.1207817. PMID15195140.
Toomes C, Bottomley HM, Scott S et al. (2004). "Spectrum and frequency of FZD4 mutations in familial exudative vitreoretinopathy". Invest. Ophthalmol. Vis. Sci.45 (7): 2083–90. doi:10.1167/iovs.03-1044. PMID15223780.
Omoto S, Hayashi T, Kitahara K et al. (2004). "Autosomal dominant familial exudative vitreoretinopathy in two Japanese families with FZD4 mutations (H69Y and C181R)". Ophthalmic Genet.25 (2): 81–90. doi:10.1080/13816810490514270. PMID15370539.
Yoshida S, Arita R, Yoshida A et al. (2004). "Novel mutation in FZD4 gene in a Japanese pedigree with familial exudative vitreoretinopathy". Am. J. Ophthalmol.138 (4): 670–1. doi:10.1016/j.ajo.2004.05.001. PMID15488808.
Qin M, Hayashi H, Oshima K et al. (2006). "Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes". Hum. Mutat.26 (2): 104–12. doi:10.1002/humu.20191. PMID15981244.
Nallathambi J, Shukla D, Rajendran A et al. (2006). "Identification of novel FZD4 mutations in Indian patients with familial exudative vitreoretinopathy". Mol. Vis.12: 1086–92. PMID17093393.